R. Daniel Mellon

1.6k total citations · 1 hit paper
16 papers, 1.2k citations indexed

About

R. Daniel Mellon is a scholar working on Cellular and Molecular Neuroscience, Immunology and Molecular Biology. According to data from OpenAlex, R. Daniel Mellon has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in R. Daniel Mellon's work include Neuropeptides and Animal Physiology (6 papers), Receptor Mechanisms and Signaling (4 papers) and Immunotoxicology and immune responses (3 papers). R. Daniel Mellon is often cited by papers focused on Neuropeptides and Animal Physiology (6 papers), Receptor Mechanisms and Signaling (4 papers) and Immunotoxicology and immune responses (3 papers). R. Daniel Mellon collaborates with scholars based in United States, United Kingdom and Germany. R. Daniel Mellon's co-authors include Bob A. Rappaport, Arthur F. Simone, Barbara Bayer, Janet Woodcock, Anne‐Marie Tobin, Timothy J. Kropp, S. Leigh Verbois, Aspandiar G. Katki, Robert Parker and Donna A. Volpe and has published in prestigious journals such as New England Journal of Medicine, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

R. Daniel Mellon

16 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs

2011 315 citations Donna A. Volpe, Anne‐Marie Tobin et al. Regulatory Toxicology and Pharmacology profile →

Peers

Countries citing papers authored by R. Daniel Mellon

Since Specialization

Citations

This map shows the geographic impact of R. Daniel Mellon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Daniel Mellon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Daniel Mellon more than expected).

Fields of papers citing papers by R. Daniel Mellon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Daniel Mellon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Daniel Mellon. The network helps show where R. Daniel Mellon may publish in the future.

Co-authorship network of co-authors of R. Daniel Mellon

This figure shows the co-authorship network connecting the top 25 collaborators of R. Daniel Mellon. A scholar is included among the top collaborators of R. Daniel Mellon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Daniel Mellon. R. Daniel Mellon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Can We Panelize Seizure? 2020 ·Toxicological Sciences ·Ruth Roberts, Simon Authier, R. Daniel Mellon, Michael J. Morton, Ikuro Suzuki, Ronald B. Tjalkens, Jean‐Pierre Valentin, Jennifer Pierson	18
2	Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular 2017 ·International Journal of Toxicology ·(unknown), (unknown), Brian Short, Tony L. Yaksh, Alison M. Bendele, (unknown), (unknown), Jay Chang, R. Daniel Mellon	55
3	HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach 2015 ·Regulatory Toxicology and Pharmacology ·Hervé Lebrec, Frank R. Brennan, Helen G. Haggerty, Danuta J. Herzyk, Cris Kamperschroer, Curtis C. Maier, Rafael Ponce, B D Preston, Daniel Weinstock, R. Daniel Mellon	15
4	Immunomodulation and lymphoma in humans 2013 ·Journal of Immunotoxicology ·Rafael Ponce, Thomas Gelzleichter, Helen G. Haggerty, Shawn M. Heidel, Matthew S. Holdren, Hervé Lebrec, R. Daniel Mellon, Marc Pallardy	17
5	Defining Safe Use of Anesthesia in Children 2011 ·New England Journal of Medicine ·Bob A. Rappaport, R. Daniel Mellon, Arthur F. Simone, Janet Woodcock	163
6	Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs breakdown → 2011 ·Regulatory Toxicology and Pharmacology ·Donna A. Volpe, Anne‐Marie Tobin, R. Daniel Mellon, Aspandiar G. Katki, Robert Parker, Thomas Colatsky, Timothy J. Kropp, S. Leigh Verbois	315
7	Compilation of International Regulatory Guidance Documents for Neuropathology Assessment During Nonclinical General Toxicity and Specialized Neurotoxicity Studies 2010 ·Toxicologic Pathology ·Brad Bolon, Alys Bradley, Mark T. Butt, Karl F. Jensen, G. Krinke, R. Daniel Mellon	26
8	Continuing Education Course #3 2010 ·Toxicologic Pathology ·Brad Bolon, Robert H. Garman, Hans Jørgen G. Gundersen, G. Allan Johnson, Wolfgang Kaufmann, G. Krinke, Peter B. Little, Susan L. Makris, R. Daniel Mellon, Kathleen K. Sulik, Karl F. Jensen	17
9	Use of Anesthetic Agents in Neonates and Young Children 2007 ·Anesthesia & Analgesia ·R. Daniel Mellon, Arthur F. Simone, Bob A. Rappaport	262
10	Altered T-cell Responsiveness in Morphine “Tolerant” Rats: Evidence for a Potential Role of the Paraventricular Nucleus of the Hypothalamus 2006 ·Kluwer Academic Publishers eBooks ·R. Daniel Mellon, (unknown), Monica C. Hernandez, Barbara Bayer	3
11	Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants 2002 ·Biochemical Pharmacology ·Xin Chen, R. Daniel Mellon, Lu Yang, Huifang Dong, Joost J. Oppenheim, O. M. Zack Howard	34
12	Reversal of acute effects of high dose morphine on lymphocyte activity by chlorisondamine 2001 ·Drug and Alcohol Dependence ·R. Daniel Mellon, Barbara Bayer	10
13	Acute Effects of Morphine on Blood Lymphocyte Proliferation and Plasma IL‐6 Levels 2000 ·Annals of the New York Academy of Sciences ·Richard A. Houghtling, R. Daniel Mellon, Roderick J. Tan, Barbara Bayer	25
14	The Effects of Morphine, Nicotine and Epibatidine on Lymphocyte Activity and Hypothalamic-Pituitary-Adrenal Axis Responses 1999 ·Journal of Pharmacology and Experimental Therapeutics ·R. Daniel Mellon, Barbara Bayer	38
15	Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s)of action 1998 ·Journal of Neuroimmunology ·R. Daniel Mellon, Barbara Bayer	119
16	Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity 1998 ·Brain Research ·R. Daniel Mellon, Barbara Bayer	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact